Stewart A. Factor

Active 1988–2026

141
Papers
23,250
Citations
86
h-index
133
i10-index

Citations

Citations per year for Stewart A. Factor1967: 1 citations1986: 1 citations1989: 1 citations1990: 1 citations1991: 2 citations1992: 2 citations1993: 4 citations1994: 4 citations1995: 8 citations1996: 8 citations1997: 16 citations1998: 19 citations1999: 28 citations2000: 37 citations2001: 62 citations2002: 83 citations2003: 103 citations2004: 79 citations2005: 77 citations2006: 95 citations2007: 117 citations2008: 126 citations2009: 112 citations2010: 119 citations2011: 173 citations2012: 161 citations2013: 225 citations2014: 155 citations2015: 198 citations2016: 211 citations2017: 240 citations2018: 272 citations2019: 750 citations2020: 847 citations2021: 792 citations2022: 680 citations2023: 524 citations2024: 822 citations2025: 406 citations2026: 39 citations1968–1985: no citations, so these years are not shown1987–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,832 citing papers, 26% of this breakdownUnited Kingdom: 958 citing papers, 8.8% of this breakdownChina: 739 citing papers, 6.8% of this breakdownGermany: 697 citing papers, 6.4% of this breakdownItaly: 587 citing papers, 5.4% of this breakdownCanada: 561 citing papers, 5.2% of this breakdownFrance: 356 citing papers, 3.3% of this breakdownSpain: 342 citing papers, 3.1% of this breakdownAustralia: 320 citing papers, 2.9% of this breakdownNetherlands: 300 citing papers, 2.8% of this breakdownIndia: 231 citing papers, 2.1% of this breakdownSweden: 201 citing papers, 1.8% of this breakdown
0%26%Other 25.4%

Fields

  • Medicine65.4%
  • Neuroscience13.2%
  • Biochemistry, Genetics and Molecular Biology12.3%
  • Computer Science2.2%
  • Health Professions2.2%
  • Psychology0.8%
  • Other3.9%

Topics

  • Parkinson's Disease Mechanisms and Treatments19%
  • Neurological disorders and treatments10%
  • Genetic Neurodegenerative Diseases2.8%
  • Botulinum Toxin and Related Neurological Disorders2.6%
  • Alzheimer's disease research and treatments2.5%
  • Nuclear Receptors and Signaling2.1%
  • Other61%

Coauthors

All papers

Open in search
  1. The Parkinson Progression Marker Initiative (PPMI)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keith A. Hawkins, Jamie L. Eberling, Deborah W. Brooks, David Russell, Laura Leary, Stewart A. Factor, Barbara Sommerfeld, Penelope Hogarth, Emily Pighetti, Karen Williams, David G. Standaert, Stephanie Guthrie, Robert A. Hauser, Holly Delgado, Joseph Jankovic, Christine Hunter, Matthew Stern, Baochan Tran, Jim Leverenz, Marne Baca, Sam Frank, Cathi-Ann Thomas, Irene Hegeman Richard, Cheryl Deeley, Linda Rees, Fabienne Sprenger, Elisabeth Lang, Holly A. Shill, Sanja Obradov, Hubert Fernandez, Adrienna Winters, Daniela Berg, Katharina Gauss, Douglas Galasko, Deborah Fontaine, Zoltán Mari, Melissa Gerstenhaber, David J. Brooks, Sophie Malloy, Paolo Barone, Katia Longo, Tom Comery, Bernard Ravina, Igor D. Grachev, Kim P. Gallagher, Michelle Collins, Katherine L. Widnell, Suzanne Ostrowizki, Paulo Fontoura, Tony W. Ho, Johan Luthman, Marcel van der Brug, Alastair D. Reith, Peggy Taylor - Progress in Neurobiology 2011 cited by 1,915

  2. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

    Authors: , , , , , , , , , , , - Movement Disorders 2017 cited by 878

  3. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease

    Authors: , , , , , , , , , , , , , - Science Advances 2020 cited by 393

  4. LRRK2 levels in immune cells are increased in Parkinson’s disease

    Authors: , , , , , , , , , , - npj Parkinson s Disease 2017 cited by 306

  5. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

    Authors: , , , , , , , , , , , , , , , , , , - Nature Genetics 2010 cited by 814

  6. Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group

    Authors: , , , , , , , , , , , , , , , , , - Movement Disorders 2007 cited by 534

  7. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raymond James, Ramon L. Rodriguez, Kyle Rizer, Karen E. Anderson, Hope Heller, Alexis Carlson, Susan R. Criswell, Brad A. Racette, Fredy J. Revilla, Frederick C. Nucifora, Russell L. Margolis, MaryJane Ong, Tilak Mendis, Neila Mendis, Carlos Singer, Mónica Quesada, Jane S. Paulsen, Thomas Brashers-Krug, Amanda C. Miller, Jane Kerr, Richard Dubinsky, Carolyn Steele Gray, Stewart A. Factor, Elaine Sperin, Eric Molho, Mary Eglow, Sharon Evans, Rajeev Kumar, Christina Reeves, Ali Samii, Sylvain Chouinard, Monica Beland, B.L. Scott, Patrick Hickey, Sherali Esmail, Wai Lun Alan Fung, Clare Gibbons, Lina Qi, Amy Colcher, Cory Hackmyer, Andrew McGarry, Kevin J. Klos, Mark Gudesblatt, Lori Fafard, Laura Graffitti, Daniel Schneider, Rohit Dhall, Joanne Wojcieszek, Kathrin LaFaver, Andrew P. Duker, Erin Neefus, Hilary Wilson, David Shprecher, Paola Wall, Karen Blindauer, Lynn Wheeler, James T. Boyd, Emily Houston, Eric S. Farbman, Pinky Agarwal, Shirley Eberly, Arthur Watts, Pierre N. Tariot, Andrew Feigin, Scott Evans, Chris Beck, Constance Orme, Jon Edicola, Emily Christopher - JAMA 2016 cited by 398

  8. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double‐blind, randomized, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2015 cited by 282

  9. Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease

    Authors: , , , , , , , , - Movement Disorders 2018 cited by 217

  10. Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joanne Wojcieszek, Lynn A. Raymond, Jody Corey‐Bloom, Victor Sung, Marissa Dean, Michael Geshwind, Alexandra Nelson, Samuel Frank, Kathrin LaFaver, Andrew P. Duker, Lawrence Elmer, Ali Samii, Yi‐Han Lin, Sylvain Chouinard, Lauren Seeberger, B.L. Scott, James Boyd, Nikolaus R. McFarland, Erin Furr Stimming, Oksana Suchowersky, Claudia Testa, Karen E. Anderson - Nature Medicine 2022 cited by 62

  11. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ruth K. Abramson, Karen Marder, Jorge Sequeiros, Jane S. Paulsen, G. Bernhard Landwehrmeyer, Richard H. Myers, Marcy E. MacDonald, James F. Gusella, Alexandra Dürr, Adam Rosenblatt, Luigi Frati, Susan B. Perlman, P. M. Conneally, Mary Lou Klimek, Melissa Diggin, Tiffany C. Hadzi, Ayana Duckett, Anwar Ahmed, Paul Allen, David Ames, Christine Anderson, Karla J. Anderson, Karen Anderson, Thomasin Andrews, John Ashburner, Eric Axelson, Elizabeth Aylward, Roger A. Barker, Katrin Barth, Stacey K. Barton, Kathleen Baynes, Alexandra Bea, Erik B. Beall, Mirza Faisal Beg, Leigh J. Beglinger, Kevin Biglan, K. Björk, Steve Blanchard, Jeremy Bockholt, Sudharshan Reddy Bommu, Bradley G. Brossman, Maggie Burrows, Vince D. Calhoun, Noelle E. Carlozzi, Amy M. Chesire, Edmond Chiu, Phyllis Chua, R.J. Connell, Carmela Connor, Jody Corey‐Bloom, David Craufurd, Stephen Cross, Lucette A. Cysique, Rachelle Dar Santos, Jennifer Davis, Joji Decolongon, A. Dipietro, Nicholas Doucette, Nancy R. Downing, Ann Dudler, Steve Dunn, Daniel Ecker, Eric A. Epping, Diane Erickson, Cheryl Erwin, Kenneth Evans, Stewart A. Factor, Sarah Tomaszewski Farias, Marta Fatas, Jess G. Fiedorowicz and 611 more - Neurology 2012 cited by 391

  12. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter G. Como, Roger Kurlan, Jeffrey M. Lyness, N. Shirlene Pearson, Barbara Sommerfeld, Cheryl Deeley, T. de la Torre, M Barnard, April Wilson, Maryann Lincoln, Paula Damgaard, Melissa Gerstenhaber, Kelly Dustin, Nancy Zappala, Camille Swartz, Mary L. Creech, E. Shipley, Samantha Blankenship, Monica Beland, Jessie Roth, Heather Burnette, Tamara E. Foxworth, Mónica Quesada, Mary Lloyd, Brenda Pfeiffer, Joy Hansen, Joy Folie, Renee Wagner, Julia Spears, Colleen Taylor, Rachel Brown, Lisa Iguchi, Chen Lim, Kori A. LaDonna, Julie Megens, Matthew Menza, Jeffrey L. Cummings, Robert M. Hamer, Kathleen M. Shannon, Joanne Odenkirchen, Robin Conwit, Christopher A. Beck, Donna LaDonna, Jan Bausch, Scott Y. H. Kim, Ron Chismar, Sinéad Quinn, Steve Bean, Susan Daigneault, Patricia Lindsay, Tori Ross, Katie Kompoliti - Neurology 2012 cited by 334

  13. A Home Diary to Assess Functional Status in Patients with Parkinson's Disease with Motor Fluctuations and Dyskinesia

    Authors: , , , , , , , - Clinical Neuropharmacology 2000 cited by 298

  14. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2015 cited by 207

  15. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sheryl Houston, Danielle Buchanan, Katherine E. McDonell, Stewart A. Factor, Elaine Sperin, Andrea Hurt, Joanne Wojcieszek, Mike Adurogbangba, Lynn A. Raymond, Jody Corey‐Bloom, Chase Snell, Courtney Blair, Victor Sung, Sophia Antonioli, Jacqueline Fung, Simon Laganiere, Luis Sierra, William Mallonee, Greg Suter, Danny Bega, Zsa Zsa Brown, Lawrence Elmer, Nancy Vollmar, Debra del Castillo, Yihan Lin, Kelly L. Andrzejewski, Patricia Weigel, Trevor Hawkins, Kendra Kirby, Cimmaron Retzik-Stahr, Lauren Seeberger, Rohit Dhall, Anja Rassmann, McKenzie Luxmore, B.L. Scott, Bisena Bulica, James T. Boyd, K. Chan, Nikolaus R. McFarland, Kyle Rizer, Patricia M. Conlon, Valerie Suski, Federico Rodríguez‐Porcel, Sandra R. Wilson, Christine Farrell, David J. Hunter, David Houghton, Sarah Seoane, Clare Gibbons, Philippe Rizek, Robin Kuprewicz, Steven Lo, Miroslav Cuturic, Vicki Segro, Kate Greenly, Fredy J. Revilla, Enrique Urrea‐Mendoza, Kevin J. Black, Thomas L. Davis, Natividad Stover, Andrew P. Duker, Jay Van Gerpen, Peter Hedera, William G. Ondo, Karen E. Anderson, Stephen Bradley, Ken Cheung, Samuel Frank - The Lancet Neurology 2023 cited by 63

  16. APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2014 cited by 210

  17. Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region

    Authors: , , , , , , , , , , - The American Journal of Human Genetics 2013 cited by 190

  18. Freezing of gait: understanding the complexity of an enigmatic phenomenon

    Authors: , , , , , , , - Brain 2019 cited by 174

  19. Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Seibyl, Susan Mendick, Norbert Schuff, Chelsea Caspell, Liz Uribe, Eric D. Foster, Katherine B. Gloer, Jon Yankey, Arthur W. Toga, Karen Crawford, Paola Casalin, Giulia Malferrari, Brit Mollenhauer, Douglas Galasko, Andrew Singleton, Keith A. Hawkins, David Russell, Stewart A. Factor, Penelope Hogarth, David G. Standaert, Robert A. Hauser, Joseph Jankovic, Matthew Stern, Lana M. Chahine, James B. Leverenz, Samuel Frank, Irene Richard, Klaus Seppi, Holly A. Shill, Hubert Fernandez, Daniela Berg, Isabel Wurster, Douglas Galasko, Zoltan Mari, David J. Brooks, Nicola Pavese, Paolo Barone, Stuart Isaacson, Alberto J. Espay, Dominic B. Rowe, Melanie Brandabur, James W. Tetrud, Grace Liang, Álex Iranzo, Eduardo Tolosa, Laura Leary, C Riordan, Linda Rees, Alicia Portillo, Art Lenahan, Karen Williams, Stephanie Guthrie, Ashlee Brooke Rawlins, Sherry Harlan, Christine Hunter, Baochan Tran, Abigail Darin, Carly Linder, Marne Baca, Heli Venkov, Cathi-Ann Thomas, Raymond James, Cheryl Deeley, Courtney Bishop, Fabienne Sprenger, Diana Willeke, Sanja Obradov, Jennifer Mule, Nancy Monahan, Katharina Gauss and 98 more - Neurology 2017 cited by 152

  20. Long-Term Dementia Risk in Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Siderowf, Douglas Galasko, Lana Chahine, Christopher S. Coffey, Kalpana Merchant, Kathleen L. Poston, Roseanne D. Dobkin, Tatiana Foroud, Brit Mollenhauer, Dan Weintraub, Ethan Brown, Karl Kieburtz, Duygu Tosun, Werner Poewe, Susan Bressman, Jan Hamer, Raymond James, Ekemini Riley, John Seibyl, Leslie M. Shaw, David G. Standaert, Sneha Mantri, Nabila Dahodwala, Michael A. Schwarzschild, Connie Marras, Hubert Fernandez, Ira Shoulson, Helen Rowbotham, Lucy Norcliffe‐Kaufmann, Paola Casalin, Claudia Trenkwalder, Todd Sherer, Sohini Chowdhury, Mark Frasier, Jamie L. Eberling, Katie Kopil, Alyssa O’Grady, James Gibaldi, Maggie Kuhl, L. Kirsch, Emily Flagg, Bridget McMahon, Craig Stanley, Kim Fabrizio, Dixie Ecklund, Trevis Huff, Richard M. Peters, Janel Fedler, Laura Heathers, Christopher Hobbick, Gena Antonopoulos, Chelsea Caspell‐Garcia, Michael C. Brumm, Arthur W. Toga, Karen Crawford, Andrew Singleton, Thomas J. Montine, Monica Korell, Ruth B. Schneider, Kelvin L. Chou, David Russell, Stewart A. Factor, Penelope Hogarth, Robert A. Hauser, Marie Saint‐Hilaire, David Shprecher, Kathrin Brockmann, Yen Tai, Paolo Barone, Stuart Isaacson and 82 more - Neurology 2024 cited by 74

  21. Freezing of Gait can persist after an acute levodopa challenge in Parkinson’s disease

    Authors: , , , , , - npj Parkinson s Disease 2019 cited by 72

  22. Stepping up to meet the challenge of freezing of gait in Parkinson’s disease

    Authors: , , , , , - Translational Neurodegeneration 2022 cited by 41

  23. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia

    Authors: , , , , , , , , - American Journal of Psychiatry 2017 cited by 394

  24. Cognitive performance of GBA mutation carriers with early-onset PD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bradley C. Hiner, Andrew Siderowf, Haydeh Payami, Eric Molho, Stewart A. Factor, Ruth Ottman, Lorraine N. Clark, Karen Marder - Neurology 2012 cited by 268